Article info

Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length

Authors

  1. Correspondence to Dr Christine Kim Garcia, Pulmonary and Critical Care Medicine, Columbia University Irving Medical Center, New York, NY 10032-3784, USA; ckg2116{at}cumc.columbia.edu
View Full Text

Citation

McGroder CF, Zhang D, Choudhury MA, et al
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length

Publication history

  • Received February 5, 2021
  • Revised April 6, 2021
  • Accepted April 13, 2021
  • First published April 29, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.